title: New agents to treat life-threatening fungal infections.
abstract: Fungi can cause life threatening diseases, particularly in patients with weakened immune systems. While treatment options are available for these individuals, dose limiting toxicity and the appearance of drug resistant organisms are growing problems. Therefore, the identification, development, and registration of new, safe, and efficacious agents are needed. Herein, we review recent developments in the field of antifungal drug discovery. We focus on recently launched drugs (triazoles and echinocandins), agents in clinical development, and compounds in discovery.
authors.affiliation: Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, NJ 07033, USA. pauline.ting@spcorp.com
authors.forename: Pauline C
authors.initials: PC
authors.lastname: Ting
authors.forename: Scott S
authors.initials: SS
authors.lastname: Walker
mesh_terms: D000935:Antifungal Agents / Q000737:chemistry* / Q000494:pharmacology / Q000627:therapeutic use*; D015195:Drug Design; D005658:Fungi / Q000187:drug effects; D006801:Humans; D015394:Molecular Structure; D009181:Mycoses / Q000188:drug therapy*
chemical_list: D000935:Antifungal Agents